Rocket Pharmaceuticals, Inc.
RCKT
$3.19
$0.103.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -26.65% | -12.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -22.55% | 5.11% | |||
| Operating Income | 22.55% | -5.11% | |||
| Income Before Tax | 26.97% | -12.37% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 26.97% | -12.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 26.97% | -12.37% | |||
| EBIT | 22.55% | -5.11% | |||
| EBITDA | 24.46% | -6.03% | |||
| EPS Basic | 27.34% | -11.43% | |||
| Normalized Basic EPS | 23.26% | -5.63% | |||
| EPS Diluted | 27.34% | -11.43% | |||
| Normalized Diluted EPS | 23.26% | -5.63% | |||
| Average Basic Shares Outstanding | 0.50% | 0.84% | |||
| Average Diluted Shares Outstanding | 0.50% | 0.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||